⌘K

Login Start Free

Home/Filings/5/0001104659-23-011814

5//SEC Filing

BOYNTON ALTON L 5

Accession 0001104659-23-011814

CIK 0001072379other

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 5:55 PM ET

Size

11.9 KB

Accession

0001104659-23-011814

Insider Transaction Report

Form 5

Period: 2022-12-31

NORTHWEST BIOTHERAPEUTICS INCNWBO

BOYNTON ALTON L

DirectorChief Executive Officer

Transactions

Gift
COMMON STOCK OPTIONS
2022-05-26−4,900,000→ 9,761,256 total
Exercise: $0.23From: 2018-05-28Exp: 2028-05-28→ COMMON STOCK PAR VALUE $0.001 (4,900,000 underlying)
Gift
COMMON STOCK OPTIONS
2022-12-06−4,500,000→ 9,761,256 total
Exercise: $0.35From: 2020-07-02Exp: 2030-12-01→ COMMON STOCK PAR VALUE $0.001 (4,500,000 underlying)
Gift
COMMON STOCK OPTIONS
2022-12-06−4,500,000→ 9,761,256 total
Exercise: $0.35From: 2020-07-02Exp: 2030-12-01→ COMMON STOCK PAR VALUE $0.001 (4,500,000 underlying)
Gift
COMMON STOCK OPTIONS
2022-07-27−3,000,000→ 9,761,256 total
Exercise: $0.35From: 2020-07-02Exp: 2030-12-01→ COMMON STOCK PAR VALUE $0.001 (3,000,000 underlying)

Footnotes (1)

[F1]GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES.

Documents

1 file

5
tm235861-1_5seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

NORTHWEST BIOTHERAPEUTICS INC

CIK 0001072379

Entity typeother

Related Parties

1

filerCIK 0001253935

Filing Metadata

Form type: 5
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 5:55 PM ET
Size: 11.9 KB

View on SEC.gov